you're reading...
Innovation

Noninvasive Colorectal Cancer Screening Tool Shows Unprecedented Detection Rates

Results of a clinical trial of Cologuard show unprecedented rates of precancer and cancer detection by a noninvasive test.
The detection rates are similar to those reported for colonoscopy. The results were published in the March 20 issue of the New England Journal of Medicine (NEJM). Cologuard was co-developed by Mayo Clinic and Exact Sciences. Cologuard, is a noninvasive sDNA test for the early detection of colorectal precancer and cancer. The Cologuard test is based on a stool

Learn more …

Advertisements

About innovationtoronto

An early look at the things coming at us that could help or hurt from global universities and research institutions

Discussion

No comments yet.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: